β-catenin mediates stress resilience through Dicer1/microRNA regulation

Nature

Volumn 516, Issue 729, 2014, Pages S1-S5

  Dias, Caroline ^a   Feng, Jian ^a   Sun, Haosheng ^a   Shao, Ning Yi ^a   Mazei Robison, Michelle S ^a,d   Damez Werno, Diane ^a   Scobie, Kimberly ^a   Bagot, Rosemary ^a   Labonté, Benoit ^a   Ribeiro, Efrain ^a   Liu, Xiaochuan ^a   Kennedy, Pamela ^a,e   Vialou, Vincent ^a,f   Ferguson, Deveroux ^a,g   Penã, Catherine ^a   Calipari, Erin S ^a   Koo, Ja Wook ^a   Mouzon, Ezekiell ^a   Ghose, Subroto ^b   Tamminga, Carol ^b   Neve, Rachael ^c   Shen, Li ^a   Nestler, Eric J ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f and Centre National de la Recherche Scientifique Unité Mixte de Recherche 8246   (France)

^g UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICER; MICRORNA; DICER 1 PROTEIN; UNCLASSIFIED DRUG; DEAD BOX PROTEIN; DICER1 PROTEIN, MOUSE; RIBONUCLEASE III;

CELL ORGANELLE; GENE EXPRESSION; NEUROLOGY; PROTEIN; RNA; RODENT; ENZYME ACTIVITY; GENOME; NERVOUS SYSTEM;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BIOGENESIS; CHRONIC STRESS; COPING BEHAVIOR; DEPRESSION; GENE CONTROL; GENETIC ASSOCIATION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL MODEL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; MALE; PROTEIN ANALYSIS; TRANQUILIZING ACTIVITY; ADAPTATION; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; SIGNAL TRANSDUCTION;

MUS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BETA CATENIN; DEAD-BOX RNA HELICASES; DEPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NEURONS; RESILIENCE, PSYCHOLOGICAL; RIBONUCLEASE III; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84923168061     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13976     Document Type: Article

References (51)

1. Madsen, T. M., Newton, S. S., Eaton, M. E., Russell, D. S. & Duman, R. S. Chronic electroconvulsive seizure up-regulates b-catenin expression in rat hippocampus: role in adult neurogenesis. Biol. Psychiatry 54, 1006-1014 (2003).
2. Beaulieu, J.-M. et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl Acad. Sci. USA 101, 5099-5104 (2004).
3. Gould, T. D. et al. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 32, 2173-2183 (2007).
4. Li, X. & Jope, R. S. Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35, 2143-2154 (2010).
5. Brennand, K. J. et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221-225 (2011).
6. Behrens, J., von Kries, J., Kü hl, M. & Bruhn, L. Functional interaction of b-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996).
7. Molenaar, M. et al. XTcf-3 transcription factor mediates b-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399 (1996).
8. van deWetering, M. et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88, 789-799 (1997).
9. Wilkinson, M. B. et al. Anovel role of theWNT-dishevelled-GSK3b signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J. Neurosci. 31, 9084-9092 (2011).
10. Sadot, E. et al. Regulation of S33/S37 phosphorylated b-catenin in normal and transformed cells. J. Cell Sci. 115, 2771-2780 (2002).
11. Berton, O. et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864-868 (2006).
12. Krishnan, V. et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131, 391-404 (2007).
13. Kolligs, F. T.,Hu, G.,Dang, C. V.&Fearon, E. R.Neoplastic transformation ofRK3Eby mutant b-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19, 5696-5706 (1999).
14. Wang, Z. et al. b-catenin promotes survival of renal epithelial cells by inhibitingBax. J. Am. Soc. Nephrol. 20, 1919-1928 (2009).
15. Rada, P. et al. Glutamate release in the nucleus accumbens is involved in behavioral depression during the Porsolt swim test. Neuroscience 119, 557-565 (2003).
16. Abe, K. & Takeichi, M. NMDA-receptor activation induces calpain-mediated b-catenin cleavages for triggering gene expression. Neuron 53, 387-397 (2007).
17. Tye, K. M. et al. Amygdala circuitrymediating reversible andbidirectional control of anxiety. Nature 471, 358-362 (2011).
18. Britt, J. P. et al. Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 76, 790-803 (2012).
19. Feng, J. et al. Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens. Genome Biol. 15, R65 (2014).
20. Shen, L. et al. diffReps: detecting differential chromatin modification sites from ChIP-seq data with biological replicates. PLoS ONE 8, e65598 (2013).
21. Hödar, C. et al. Genome-wide identification of new Wnt/b-catenin target genes in the human genome using CART method. BMC Genomics 11, 348 (2010).
22. Wexler, E. M. et al. Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways. Sci. Signal. 4, ra65 (2011).
23. Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366 (2001).
24. Cuellar, T. L. et al. Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc. Natl Acad. Sci. USA 105, 5614-5619 (2008).
25. Lee, E. J. et al. Identification of piRNAs in the central nervous system. RNA 17, 1090-1099 (2011).
26. Rajasethupathy, P. et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 149, 693-707 (2012).
27. Graybiel, A. M. The basal ganglia. Curr. Biol. 10, R509-R511 (2000).
28. Gerfen, C. R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15, 285-320 (1992).
29. Kravitz, A. V., Tye, L. D.& Kreitzer, A. C. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nature Neurosci. 15, 816-818 (2012).
30. Lobo, M. K.&Nestler, E. J. The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Front. Neuroanat. 5, 41 (2011).
31. Hikida, T., Kimura, K., Wada, N., Funabiki, K. & Nakanishi, S. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66, 896-907 (2010).
32. Darvas, M. & Palmiter, R. Contributions of striatal dopamine signaling to the modulation of cognitive flexibility. Biol. Psychiatry 69, 704-707 (2011).
33. Yawata, S., Yamaguchi, T., Danjo, T., Hikida, T. & Nakanishi, S. Pathway-specific control of reward learning and its flexibility via selective dopamine receptors in the nucleus accumbens. Proc. Natl Acad. Sci. USA 109, 12764-12769 (2012).
34. Southwick, S. M. & Charney, D. S. The science of resilience: implications for the prevention and treatment of depression. Science 338, 79-82 (2012).
35. Veronese, A. et al. Mutated b-catenin evades a microRNA-dependent regulatory loop. Proc. Natl Acad. Sci. USA 108, 4840-4845 (2011).
36. Kosik, K. S. The neuronal microRNA system. Nature Rev. Neurosci. 7, 911-920 (2006).
37. Im, H.-I. & Kenny, P. J. MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 35, 325-334 (2012).
38. Issler, O. et al. MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron 83, 344-360 (2014).
39. Robison, A. J. et al. Fluoxetine epigenetically alters the CaMKIIa promoter in nucleus accumbens to regulate DFosB binding and antidepressant effects. Neuropsychopharmacology 39, 1178-1186 (2014).
40. Schmittgen, T. D.& Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nature Protocols 3, 1101-1108 (2008).
41. Lobo, M. K. et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330, 385-390 (2010).
42. Koo, J. W. et al. BDNF is a negative modulator of morphine action. Science 338, 124-128 (2012).
43. Chaudhury, D. et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493, 532-536 (2013).
44. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
45. Shen, L., Shao, N., Liu, X. & Nestler, E. ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics 15, 284 (2014).
46. Hackenberg, M., Rodrguez-Ezpeleta, N. & Aransay, A. M. MiRanalyzer: An update on the detection and analysis of microRNAs in high-throughput sequencing experiments. Nucleic Acids Res. 39 (Suppl. 2), W132-W138 (2011).
47. Griffiths-Jones, S. miRBase: the microRNA sequence database. Methods Mol. Biol. 342, 129-138 (2006).
48. Sai Lakshmi, S. & Agrawal, S. piRNABank: a web resource on classified and clustered Piwi-interacting RNAs. Nucleic Acids Res. 36 (Suppl. 1), W173-W177 (2008).
49. Kozomara, A. & Griffiths-Jones, S. MiRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68-D73 (2014).
50. Burge, S. W. et al. Rfam 11.0: 10 years of RNA families. Nucleic Acids Res. 41, D226-D232 (2013).
51. Goodstadt, L. Ruffus: A lightweight python library for computational pipelines. Bioinformatics 26, 2778-2779 (2010).